We are pleased to invite researchers, academicians, and industry experts to submit abstracts for presentation at The International Symposium on Assisted Reproductive Technology & Extracellular Vesicle Science (ARTEV), focusing on Assisted Reproductive Technology (ART) and Extracellular Vesicles (EVs). This conference provides a platform for knowledge exchange, cutting-edge discussions, and advancements in reproductive medicine, cellular communication, and therapeutic applications of EVs.
Important Dates
| Abstracts Submission Deadline | 30th June 2025 |
| Abstract Review | 1st – 31st July 2025 |
| Abstracts Acceptance Notification | 1st August 2025 |
| Submission of Full Paper | 1st September 2025 |
Conference Themes
We welcome submissions on, but not limited to, the following topics:
ART
- Advances in In Vitro Fertilization (IVF) Techniques
- Embryo Culture and Development
- Assisted Reproductive Technology and Genetics
- Innovations in Fertility Preservation
- Infertility: Diagnosis and Treatment
- Technological Advances in ART Laboratories
- Ethical and Social Implications of ART
- Emerging Trends and Future Directions in ART
- Collaborative Research and Global Cooperation in ART
- Case Studies and Clinical Trials in ART
EVs
- Fundamental Biology of Extracellular Vesicles
- EV Isolation and Characterization Techniques
- EVs in Diseases and Cancers
- EVs in Infectious Disease
- Technological Innovations in EV Research
- EVs as Drug Delivery Vehicles
- Clinical Translation of EVs
- Ethical, Social, and Regulatory Aspects of EV Research
- EVs in Plant and Animal Science
- Innovative Applications of EVs
- Future Directions and Emerging Trends in EV Research
Eligibility Criteria
- Abstract of original research and should NOT have been presented or published at any local or international scientific journal and conferences.
- Participants may submit more than ONE abstract.
- Abstracts must be in ENGLISH.
- It is the presenter's responsibility to obtain the necessary approvals, including ethical approval where applicable, for studies involving the Ministry of Health, Ministry of Health data, and human-related research.
- All clinical studies will be considered. This includes observational or interventional studies, cross sectional surveys, case series, and case reports.
- The Scientific Committee reserves the right to decide on the acceptance of abstracts for poster presentation.
Submission Guidelines
- All abstracts must be submitted online. CLICK HERE
- For any problem with abstract submission or need to amend the submission, kindly contact the ARTEV Secretariat at secretariate@artev2025.com.
- Abstracts must be submitted by 11.59 pm (MYT, GMT+8) of 30 June 2025. Late submissions or incomplete abstracts will not be accepted.
- The Secretariat will notify participants regarding the results of their submission by 1 August 2025.
Abstract Format
- The abstract should not exceed 250 words limit and include the following components: Background, Objectives, Methods, Results and Discussion, and Conclusion.
- Author(s)’ name must be written in FULL. Do not include professional title or degrees. List any institutional affiliation, state, and country.
- Abstract title must be in Title Case, e.g. “Cardiovascular Problems in Community Settings”. Title should be brief and clearly indicate the content of the abstract.
- Do not include graphs, tables, figures, or references in the abstract.
- An abbreviation must be defined by placing it in parenthesis after the full word for the first time it appears.
- Use numerals to represent numbers except when beginning a sentence.
